A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles
Abstract Malaria is a highly prevalent parasitic disease in regions with tropical and subtropical climates worldwide. Among the species of Plasmodium causing human malaria, P. vivax is the second most prevalent and the most geographically widespread species. A major target of a pre-erythrocytic vacc...
Guardado en:
Autores principales: | Alba Marina Gimenez, Ahmed M. Salman, Rodolfo F. Marques, César López-Camacho, Kate Harrison, Young Chan Kim, Chris J. Janse, Irene S. Soares, Arturo Reyes-Sandoval |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/adecc0ad11fd480ebf4d67623bca4048 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Serological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients
por: Mehdi Nateghpour, et al.
Publicado: (2021) -
PLASMODIUM VIVAX MALARIA: CLINICAL COURSE AND FREQUENCY OF RESISTANCE AGAINST CHLOROQUINE
por: Muhammad Asif Nizami, et al.
Publicado: (2021) -
In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP)
por: Merricka C. Livingstone, et al.
Publicado: (2021) -
Plasmodium vivax malaria endemicity in Indonesia in 2010.
por: Iqbal R F Elyazar, et al.
Publicado: (2012) -
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
por: Katherine L. Mallory, et al.
Publicado: (2021)